HKUMed pioneers the world's first hybrid photosensitive immunotherapy for a breakthrough in cancer treatment

Breakthrough discovery: HKUMed identifies novel gene behind neurodevelopmental syndrome for enhanced clinical treatment

HKUMed meta-analysis links high-risk Epstein-Barr virus lineage to nasopharyngeal cancer in southern China

New Cancer Treatment Breakthrough: HKUMed develops dual anti-tumour vaccine

HKUMed discovers a diagnostic potential of the amniotic fluid cells RNA-sequencing in deciphering rare diseases

HKUMed discovers glucose control may improve the antitumour activity of γδ-T cells in diabetes

HKUMed identifies home as the primary route of COVID-19 transmission among Hong Kong children and adolescents, calls for action on their psychosocial well-being due to the pandemic and school closure

HKUMed identifies rarely documented pharmacogenetic variants commonly found among Hong Kong Chinese, highlighting the potential for personalised medicine